Skip to main content

Cannabis and cannabinoids preclinical pharmacology

  1. Multiple therapeutic properties have been attributed to Cannabis sativa. However, further research is required to unveil the medicinal potential of Cannabis and the relationship between biological activity and ch...

    Authors: Bruno Musetti, Helena González-Ramos, Mercedes González, Edward M. Bahnson, Javier Varela and Leonor Thomson

    Citation: Journal of Cannabis Research 2020 2:37

    Content type: Original research

    Published on:

  2. Cannabis contains Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) as the primary constituents responsible for pharmacological activity. However, there are numerous additional chemically-related structures ...

    Authors: Alykhan Devsi, Brett Kiyota, Theophile Ouellette, Andrew P. Hegle, Ricardo E. Rivera-Acevedo, Jasper Wong, Ying Dong, Michael K. Pugsley and Timothy Fung

    Citation: Journal of Cannabis Research 2020 2:17

    Content type: Original research

    Published on:

  3. Substantial advancements were achieved in the management of postoperative pain, however the need for further improvement remains. This study explores the pharmacokinetics and safety of the CannaHaler, a metere...

    Authors: Offir Ben-Ishay, Ortal Bar-On and Yoram Kluger

    Citation: Journal of Cannabis Research 2020 2:15

    Content type: Original research

    Published on:

  4. Chronic obstructive pulmonary disease (COPD) is commonly associated with both a pro-inflammatory and a T-helper 1 (Th1) immune response. It was hypothesized that cannabis oil extract can alleviate COPD symptom...

    Authors: Stephen W. Mamber, Volkan Gurel, Jeremy Lins, Fred Ferri, Sarah Beseme and John McMichael

    Citation: Journal of Cannabis Research 2020 2:5

    Content type: Original research

    Published on: